Loading insider details...
Latest Form 4 (Nov 6, 2026): Grant/Award of 34,500 PYXS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 6, 2026 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 34,500 | n/a |
| Mar 25, 2026 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 45,867 | n/a |
| Mar 25, 2026 | Pyxis Oncology, Inc. (PYXS) | Sale | 1,400 | $1.4K |
| Apr 2, 2025 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 36,979 | $36.2K |
| Mar 28, 2024 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 38,741 | n/a |
| Mar 28, 2023 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 58,064 | n/a |
| Aug 15, 2022 | Pyxis Oncology, Inc. (PYXS) | Grant/Award | 236,220 | n/a |
| Feb 19, 2021 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 60,000 | n/a |
| Sep 10, 2020 | Black Diamond Therapeutics, Inc. (BDTX) | Grant/Award | 10,000 | n/a |